BACKGROUND: Corpus callosum is the most important commissure of the brain and therefore represents a first-choice candidate to challenge hypotheses of disrupted inter-hemispheric connectivity and white matter pathology in patients with schizophrenia. Recent studies on diffusion tensor imaging (DTI) of corpus callosum yielded promising but equivocal evidence of reduced fractional anisotropy (FA) in schizophrenia patients who were, for the most part, chronic cases on medication for a lengthy period of time. To exclude potentially confounding effects of the course of the disorder and its treatment, we compared callosal FA of first-contact, antipsychotic drug-naive schizophrenia patients (n=21) and healthy controls (n=21). METHODS: Splenium and genu FA were obtained by two independent observers utilizing large, rectangular, tractography-guided regions of interest outlined on directional color-coded maps. Inter-observer agreement on FA was evaluated by means of the Bland and Altman and the Passing and Bablok procedures together with an estimate of the intra-class correlation coefficient. RESULTS: Strong inter-observer agreement of FA values emerged from each of the three statistical approaches utilized. ANCOVA showed a significant effect on FA for the interaction between patient-control membership and callosal region (F=5.354; p=0.026); post hoc multiple comparisons demonstrated that, when compared to the controls, the patients had lower mean FA values (p=0.005) in the splenium but not in the genu and that this difference tended to be more evident in males (p=0.090). CONCLUSIONS: Lowered mean FA values in the splenium of first-contact, antipsychotic drug-naive patients with respect to healthy controls strongly support the hypothesis that processes operant at least since the earliest phases of the disorder and independent from exposition to antipsychotic drugs contribute to reduced anisotropy in schizophrenia.
BACKGROUND: Corpus callosum is the most important commissure of the brain and therefore represents a first-choice candidate to challenge hypotheses of disrupted inter-hemispheric connectivity and white matter pathology in patients with schizophrenia. Recent studies on diffusion tensor imaging (DTI) of corpus callosum yielded promising but equivocal evidence of reduced fractional anisotropy (FA) in schizophreniapatients who were, for the most part, chronic cases on medication for a lengthy period of time. To exclude potentially confounding effects of the course of the disorder and its treatment, we compared callosal FA of first-contact, antipsychotic drug-naive schizophreniapatients (n=21) and healthy controls (n=21). METHODS: Splenium and genu FA were obtained by two independent observers utilizing large, rectangular, tractography-guided regions of interest outlined on directional color-coded maps. Inter-observer agreement on FA was evaluated by means of the Bland and Altman and the Passing and Bablok procedures together with an estimate of the intra-class correlation coefficient. RESULTS: Strong inter-observer agreement of FA values emerged from each of the three statistical approaches utilized. ANCOVA showed a significant effect on FA for the interaction between patient-control membership and callosal region (F=5.354; p=0.026); post hoc multiple comparisons demonstrated that, when compared to the controls, the patients had lower mean FA values (p=0.005) in the splenium but not in the genu and that this difference tended to be more evident in males (p=0.090). CONCLUSIONS: Lowered mean FA values in the splenium of first-contact, antipsychotic drug-naive patients with respect to healthy controls strongly support the hypothesis that processes operant at least since the earliest phases of the disorder and independent from exposition to antipsychotic drugs contribute to reduced anisotropy in schizophrenia.
Authors: Thomas J Whitford; Peter Savadjiev; Marek Kubicki; Lauren J O'Donnell; Douglas P Terry; Sylvain Bouix; Carl-Fredrik Westin; Jason S Schneiderman; Laurel Bobrow; Andrew C Rausch; Margaret Niznikiewicz; Paul G Nestor; Christos Pantelis; Stephen J Wood; Robert W McCarley; Martha E Shenton Journal: Schizophr Res Date: 2011-08-09 Impact factor: 4.939
Authors: Andrew Zalesky; Alex Fornito; Marc L Seal; Luca Cocchi; Carl-Fredrik Westin; Edward T Bullmore; Gary F Egan; Christos Pantelis Journal: Biol Psychiatry Date: 2010-10-29 Impact factor: 13.382
Authors: Thomas J Whitford; Marek Kubicki; Shahab Ghorashi; Jason S Schneiderman; Kathryn J Hawley; Robert W McCarley; Martha E Shenton; Kevin M Spencer Journal: Neuroimage Date: 2010-10-25 Impact factor: 6.556
Authors: Katie L Nugent; Joshua Chiappelli; Hemalatha Sampath; Laura M Rowland; Kavita Thangavelu; Beshaun Davis; Xiaoming Du; Florian Muellerklein; Stacey Daughters; Peter Kochunov; L Elliot Hong Journal: Psychosom Med Date: 2015-09 Impact factor: 4.312
Authors: Emily C Balevich; M Mehmet Haznedar; Eugene Wang; Randall E Newmark; Rachel Bloom; Jason S Schneiderman; Jonathan Aronowitz; Cheuk Y Tang; King-Wai Chu; William Byne; Monte S Buchsbaum; Erin A Hazlett Journal: Psychiatry Res Date: 2015-01-08 Impact factor: 3.222
Authors: Alan N Francis; Suraj S Mothi; Ian T Mathew; Neeraj Tandon; Brett Clementz; Godfrey D Pearlson; John A Sweeney; Carol A Tamminga; Matcheri S Keshavan Journal: Biol Psychiatry Date: 2016-01-12 Impact factor: 13.382
Authors: Serge A Mitelman; Yekaterina K Nikiforova; Emily L Canfield; Erin A Hazlett; Adam M Brickman; Lina Shihabuddin; Monte S Buchsbaum Journal: Schizophr Res Date: 2009-08-26 Impact factor: 4.939